Drugmakers Halt Autoimmune Trials After Deaths, Life-Threatening Side Effects
Trial freezes by Novartis and Bristol Myers have triggered a race to understand why a promising autoimmune treatment turned risky.
The Edge of the Cyber World See the latest
Trial freezes by Novartis and Bristol Myers have triggered a race to understand why a promising autoimmune treatment turned risky.
Jobs and wages are booming in counties that welcome AI.
The fitness tracker recently turned profitable and posted 74% revenue growth in the nine months ended in June.
Find insight on Nvidia, Broadcom, HPE and more in the latest Market Talks covering technology, media and telecom.
At Uber and elsewhere, managers with small fiefdoms have become an especially vulnerable target in the push to purge management ranks.
They are about innovators, once heralded as making the world a better place, trading their lofty virtuous ambitions for profits and power.
Plus, Nvidia agrees to buy Hugging Face for $13 billion
The deal comes as Nvidia ramps up efforts to develop open-weight models and related services.
China’s Moonshot AI has confidentially submitted an application for an initial public offering to Hong Kong’s stock exchange, people familiar with the matter said.